The Cooper Companies, Inc. COO
55.38
0.00
0.00%
as of 25 Sep
- Market cap
- $10.5B
- P/E
- 18.9×
Follow COO
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
The Cooper Companies, Inc. (COO) P/S ratio
As of 25 September 2026, The Cooper Companies, Inc. (COO) trades at a P/S ratio of 2.5×. Over the past ten years it has ranged from 2.4× (September 2026) to 8.2× (April 2021); the current reading is higher than 0% of that period. That is below the Medical Instruments & Supplies industry median of 2.8× and below the Healthcare sector median of 3.8×.
P/S ratio, daily
Annual
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 3.4× | (36.37%) |
| FY2024 | 5.3× | 24.52% |
| FY2023 | 4.3× | 5.26% |
| FY2022 | 4.1× | (42.59%) |
| FY2021 | 7.1× | 9.73% |
| FY2020 | 6.5× | 19.50% |
| FY2019 | 5.4× | 8.19% |
| FY2018 | 5.0× | (8.84%) |
| FY2017 | 5.5× | 26.54% |
| FY2016 | 4.3× | 3.93% |
Quarterly
| Period | P/S ratio | Change |
|---|---|---|
| Jul 2026 | 3.3× | 13.64% |
| Apr 2026 | 2.9× | (23.78%) |
| Jan 2026 | 3.8× | 11.83% |
| Oct 2025 | 3.4× | (2.33%) |
| 43 more quarters | Free account |
Against its own ten years
Low 2.4×
High 8.2×
Ten-year median
5.0×
Current reading's percentile
0
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| BAX Baxter International Inc. compare | 1.1× |
| BLCO Bausch + Lomb Corporation compare | 1.1× |
| AVTR Avantor, Inc. compare | 1.6× |
| SOLV Solventum Corporation compare | 1.9× |
| ATR AptarGroup, Inc. compare | 2.0× |
| COO The Cooper Companies, Inc. | 2.5× |
| ALGN Align Technology, Inc. compare | 2.5× |
| STVN Stevanato Group S.p.A. compare | 4.0× |
| RGEN Repligen Corporation compare | 13.6× |
| Medical Instruments & Supplies industry median | 2.8× |
| Healthcare sector median | 3.8× |
| Market median | 2.0× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on COO
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement